Operator
Good morning, and welcome to the Boston Scientific Fourth Quarter 2020 Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference over to Susan Lisa, Vice President, Investor Relations. Please go ahead.
Susie Lisa
Vice President, Investor Relations
Thank you, Andrew. Good morning, everyone, and thanks for joining us. With me on today s call are Mike Mahoney, Chairman and Chief Executive Officer and Dan Brennan, Executive Vice President and Chief Financial Officer. We issued a press release earlier this morning announcing our Q4 2020 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today s call to the Investor Relations section of our website under the heading Financials & Filings.
Boston Scientific Launches WaveWriter Alpha Spinal Cord Stimulator Systems In U.S.
WASHINGTON (dpa-AFX) - Boston Scientific (BSX) announced Thursday a limited market release of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems. This is an unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs).
The provide uncompromised personalization, and for the first time in SCS, Fast Acting Sub-perception Therapy (FAST) designed to deliver profound paresthesia-free pain relief in minutes.
The systems are supported by the Cognita Solutions suite of digital tools to address common challenges in pain management, including raising awareness about drug-free pain management options, helping patients find local physicians, and helping physicians sustain functional outcomes for patients over the long-term.
Marlborough medical device manufacturer Boston Scientific Corp. has announced a limited market release of a new pain-relief system that uses electrical impulses in the spine to block pain signals.
Share this article
Share this article
MARLBOROUGH, Mass., Jan. 14, 2021 /PRNewswire/ Boston Scientific (NYSE: BSX) has announced a limited market release of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) systems. The unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators (IPGs) provides uncompromised personalization, and for the first time in SCS, Fast Acting Sub-perception Therapy (FAST™) designed to deliver profound paresthesia-free pain relief in minutes.
i The systems are supported by the Cognita™ Solutions suite of digital tools for patients and physicians.
Patient experience with FAST™
The Next Era of Personalization
The new WaveWriter Alpha™ Spinal Cord Stimulation Systems offer a comprehensive full-body MRI-conditional portfolio, advanced therapies and a suite of digital solutions for physicians and patients with chronic pain.
/PRNewswire/ Boston Scientific Corporation (NYSE: BSX) generated net sales, based upon preliminary unaudited financial information, of approximately $2.71.